DOE Patents title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Human Immunodeficiency Virus type 1 group M consensus and mosaic envelope glycoproteins

Abstract

The disclosure relates to nucleic acids mosaic clade M HIV-1 Env polypeptides and to compositions and vectors comprising same. The nucleic acids are suitable for use in inducing an immune response to HIV-1 in a human.

Inventors:
; ; ; ; ;
Issue Date:
Research Org.:
Los Alamos National Lab. (LANL), Los Alamos, NM (United States)
Sponsoring Org.:
USDOE
OSTI Identifier:
1410329
Patent Number(s):
9821053
Application Number:
14/689,995
Assignee:
Duke University (Durham, NC); Los Alamos National Security, LLC (Los Alamos, NM); The UAB Research Foundation (Birmingham, AL); Beth Israel Deaconess Medical Center (Boston, MA)
Patent Classifications (CPCs):
C - CHEMISTRY C07 - ORGANIC CHEMISTRY C07K - PEPTIDES
C - CHEMISTRY C12 - BIOCHEMISTRY C12N - MICROORGANISMS OR ENZYMES
DOE Contract Number:  
AC52-06NA25396
Resource Type:
Patent
Resource Relation:
Patent File Date: 2015 Apr 17
Country of Publication:
United States
Language:
English
Subject:
60 APPLIED LIFE SCIENCES; 59 BASIC BIOLOGICAL SCIENCES

Citation Formats

Korber, Bette T., Fischer, William, Liao, Hua-Xin, Haynes, Barton F., Letvin, Norman, and Hahn, Beatrice H.. Human Immunodeficiency Virus type 1 group M consensus and mosaic envelope glycoproteins. United States: N. p., 2017. Web.
Korber, Bette T., Fischer, William, Liao, Hua-Xin, Haynes, Barton F., Letvin, Norman, & Hahn, Beatrice H.. Human Immunodeficiency Virus type 1 group M consensus and mosaic envelope glycoproteins. United States.
Korber, Bette T., Fischer, William, Liao, Hua-Xin, Haynes, Barton F., Letvin, Norman, and Hahn, Beatrice H.. Tue . "Human Immunodeficiency Virus type 1 group M consensus and mosaic envelope glycoproteins". United States. https://www.osti.gov/servlets/purl/1410329.
@article{osti_1410329,
title = {Human Immunodeficiency Virus type 1 group M consensus and mosaic envelope glycoproteins},
author = {Korber, Bette T. and Fischer, William and Liao, Hua-Xin and Haynes, Barton F. and Letvin, Norman and Hahn, Beatrice H.},
abstractNote = {The disclosure relates to nucleic acids mosaic clade M HIV-1 Env polypeptides and to compositions and vectors comprising same. The nucleic acids are suitable for use in inducing an immune response to HIV-1 in a human.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {2017},
month = {11}
}

Works referenced in this record:

Delivery of exogenous DNA sequences in a mammal
patent, December 1996


Generation of antibodies through lipid mediated DNA delivery
patent, December 1997


Stabilized viral envelope proteins and uses thereof
patent, March 2004


Ancestral and COT viral sequences, proteins and immunogenic compositions
patent, February 2010


Immunogenic compositions comprising human immunodeficiency virus (HIV) mosaic Nef proteins
patent, February 2012


Human immunodeficiency virus type 1 clade M mosaic gag polypeptides
patent, April 2015


Antigen Library Immunization
patent-application, December 2002


Method for the development of an HIV vaccine
patent-application, June 2003


Polyvalent immunogen
patent-application, August 2003


Immunogenic, cross-clade, HIV peptides
patent-application, September 2003


Peptide compositions for the treatment and prevention of HIV infection
patent-application, October 2003


Polyvalent immunogen
patent-application, January 2004


Ancestral and COT viral sequences, proteins and immunogenic compositions
patent-application, June 2005


Immunogenic hiv-1 multi-clade, multivalent constructs and methods of their use
patent-application, September 2006


HIV vaccines based on Env of multiple clades of HIV
patent-application, December 2006


Consensus/ancestral immunogens
patent-application, August 2007


Polyvalent Vaccine
patent-application, December 2009


Polyvalent Vaccine
patent-application, June 2011


Polyvalent Vaccine
patent-application, May 2012


HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus
journal, November 2002


A New Variant Cytotoxic T Lymphocyte Escape Mutation in HLA-B27-Positive Individuals Infected with HIV Type 1
journal, May 2005


Control of Viremia and Prevention of Clinical AIDS in Rhesus Monkeys by Cytokine-Augmented DNA Vaccination
journal, October 2000


Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys
journal, February 2010


Viral Escape from Dominant Simian Immunodeficiency Virus Epitope-Specific Cytotoxic T Lymphocytes in DNA-Vaccinated Rhesus Monkeys
journal, July 2003


Human Immunodeficiency Virus-Specific Responses in Adult Ugandans: Patterns of Cross-Clade Recognition
journal, March 2005


HIV-1 Nef Downregulates MHC-I by a PACS-1- and PI3K-Regulated ARF6 Endocytic Pathway
journal, December 2002


Prospects for an AIDS vaccine
journal, March 2004


HIV-1 Viral Escape in Infancy Followed by Emergence of a Variant-Specific CTL Response
journal, June 2005


Polyvalent vaccines for optimal coverage of potential T-cell epitopes in global HIV-1 variants
journal, December 2006


Consistent Cytotoxic-T-Lymphocyte Targeting of Immunodominant Regions in Human Immunodeficiency Virus across Multiple Ethnicities
journal, February 2004


The end or the beginning of the drive to an HIV-preventive vaccine: a view from over 20 years
journal, September 2005


Diversity Considerations in HIV-1 Vaccine Selection
journal, June 2002


Glycosylation Site-Specific Analysis of Clade C HIV-1 Envelope Proteins
journal, September 2009


Codon usage limitation in the expression of HIV-1 envelope glycoprotein
journal, March 1996


DNA multi-CTL epitope vaccines for HIV and Plasmodium falciparum: immunogenicity in mice
journal, February 1998


Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates
journal, January 2014


Improved Vaccine Protection from Simian AIDS by the Addition of Nonstructural Simian Immunodeficiency Virus Genes
journal, December 2005


Determinants of Human Immunodeficiency Virus Type 1 Escape from the Primary CD8+ Cytotoxic T Lymphocyte Response
journal, November 2004


Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA
journal, December 2004


Clonal breadth of the HIV-1-specific T-cell receptor repertoire in vivo as determined by subtractive analysis
journal, January 2005


Expanded Breadth of the T-Cell Response to Mosaic Human Immunodeficiency Virus Type 1 Envelope DNA Vaccination
journal, December 2008


Immunogenicity of Multiple Gene and Clade Human Immunodeficiency Virus Type 1 DNA Vaccines
journal, November 2003


Evolutionary and immunological implications of contemporary HIV-1 variation
journal, September 2001


T-Cell Vaccine Strategies for Human Immunodeficiency Virus, the Virus with a Thousand Faces
journal, May 2009


T Cell Cross-Reactivity and Conformational Changes during TCR Engagement
journal, December 2004


A group M consensus envelope glycoprotein induces antibodies that neutralize subsets of subtype B and C HIV-1 primary viruses
journal, September 2006


Hierarchical Targeting of Subtype C Human Immunodeficiency Virus Type 1 Proteins by CD8+ T Cells: Correlation with Viral Load
journal, March 2004


HIV VACCINES
journal, December 2005


CD8+ T Cell Epitope-Flanking Mutations Disrupt Proteasomal Processing of HIV-1 Nef
journal, September 2005


Urgently needed: a filter for the HIV-1 vaccine pipeline
journal, August 2004


HIV vaccine strategies
journal, February 2002


Fine Specificity and Cross-Clade Reactivity of HIV Type 1 Gag-Specific CD4+ T Cells
journal, March 2004


HIV‐Specific Cellular Immune Response Is Inversely Correlated with Disease Progression as Defined by Decline of CD4+ T Cells in Relation to HIV RNA Load
journal, April 2004

  • Oxenius, Annette; Price, David A.; Hersberger, Martin
  • The Journal of Infectious Diseases, Vol. 189, Issue 7, p. 1199-1208
  • https://doi.org/10.1086/382028

Replicating Ad-recombinants encoding non-myristoylated rather than wild-type HIV Nef elicit enhanced cellular immunity
journal, January 2006


Recombination in HIV-1
journal, March 1995


A centralized gene-based HIV-1 vaccine elicits broad cross-clade cellular immune responses in rhesus monkeys
journal, July 2008


Mosaic vaccines elicit CD8+ T lymphocyte responses that confer enhanced immune coverage of diverse HIV strains in monkeys
journal, February 2010


Use of T Cell Epitopes for Vaccine Development
journal, November 2001


Control of Viremia in Simian Immunodeficiency Virus Infection by CD8+ Lymphocytes
journal, February 1999


Polygene DNA vaccine induces a high level of protective effect against HIV-vaccinia virus challenge in mice
journal, September 2004


The Role of T Cell Antagonism and Original Antigenic Sin in Genetic Immunization
journal, December 2002


Toward an AIDS Vaccine
journal, May 2008


Cross-Subtype T-Cell Immune Responses Induced by a Human Immunodeficiency Virus Type 1 Group M Consensus Env Immunogen
journal, June 2006


Characterization and Selection of HIV-1 Subtype C Isolates for Use in Vaccine Development
journal, February 2003